Alveolus Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $20.1M

Alveolus General Information

Description

Developer of non-vascular interventional stent technology intended to offer pulmonary, gastrointestinal, and ancillary products. The company technology for hospitals, physicians, and patients creates an artificial pathway, support structure, and opening for hollow lumen organs that are closed or obstructed due to cancerous lesions or benign diseases enabling interventional pulmonologists, gastroenterologists, and radiologists to give better treatment.

Contact Information

Website
www.alveolus.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9013 Perimeter Woods
  • Suite A
  • Charlotte, NC 28216
  • United States
+1 (704)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Acquirer
Merit Medical Systems
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 9013 Perimeter Woods
  • Suite A
  • Charlotte, NC 28216
  • United States
+1 (704)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alveolus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 09-Mar-2009 $20.1M Completed Generating Revenue
9. Later Stage VC (Series E) 08-Sep-2008 Completed Generating Revenue
8. Later Stage VC (Series D) 09-May-2007 Completed Generating Revenue
7. Later Stage VC 20-Mar-2006 Completed Generating Revenue
6. Early Stage VC 03-Aug-2004 Completed Generating Revenue
5. Early Stage VC (Series B) 30-Jul-2004 Completed Generating Revenue
4. Early Stage VC (Series A3) 24-Jun-2004 Completed Product Development
3. Early Stage VC (Series A2) 30-Sep-2003 Completed Product Development
2. Early Stage VC (Series A1) 12-Mar-2003 $2.04M $2.66M Completed Product Development
1. Early Stage VC (Series A) 03-Jul-2002 $620K $620K Completed Product Development
To view Alveolus’s complete valuation and funding history, request access »

Alveolus Patents

  • 57

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Alveolus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080019427-A1 False channel detection for wireless communication Active 21-Jul-2006
US-7852971-B2 False channel detection for wireless communication Active 21-Jul-2006
WO-2006124822-A1 Delivery device allowing visual inspection of an intravascular site Inactive 13-May-2005
WO-2007021322-A1 Delivery device with viewing window and associated method Inactive 13-May-2005
WO-2006124824-A1 Drainage stent and associated method Inactive 13-May-2005 A61F2/856
To view Alveolus’s complete patent history, request access »

Alveolus Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
ATEL Capital Group Asset Manager Minority
EGS Healthcare Capital Partners PE/Buyout Minority
FCA Venture Partners Venture Capital Minority
Lumira Ventures Venture Capital Minority
MB Venture Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Alveolus FAQs

  • When was Alveolus founded?

    Alveolus was founded in 2001.

  • Where is Alveolus headquartered?

    Alveolus is headquartered in Charlotte, NC.

  • What industry is Alveolus in?

    Alveolus’s primary industry is Surgical Devices.

  • Is Alveolus a private or public company?

    Alveolus is a Private company.

  • What is the current valuation of Alveolus?

    The current valuation of Alveolus is .

  • What is Alveolus’s current revenue?

    The current revenue for Alveolus is .

  • How much funding has Alveolus raised over time?

    Alveolus has raised $28M.

  • Who are Alveolus’s investors?

    ATEL Capital Group, EGS Healthcare Capital Partners, FCA Venture Partners, Lumira Ventures, and MB Venture Partners are 5 of 8 investors who have invested in Alveolus.

  • When was Alveolus acquired?

    Alveolus was acquired on 09-Mar-2009.

  • Who acquired Alveolus?

    Alveolus was acquired by Merit Medical Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process